Newsroom

BioWorld | Onquality raises combined $35M for cancer supportive care pipeline

By David Ho HONG KONG – Onquality Pharmaceuticals LLC raised an additional $20 million from a series A+ financing round, bringing its...

WSJ Pro Venture Capital I VC Daily: Startups Use Technology to Help Drugmakers Bring More Diverse

By Brian Gormley Good day. Venture-backed companies are using technology to help drugmakers bring more diverse populations of patients...

OnQuality Pharmaceuticals Announces Closing of $35 Million Series A and A+ Financing

SEATTLE and SHANGHAI—March 31, 2021. OnQuality Pharmaceuticals LLC ("OnQuality"), a targeted cancer supportive care company developing me...

BioSpace I OnQuality Pharma Raises $20 Million to Support Ongoing Oncodermatology Trial

By Gail Dutton OnQuality Pharmaceuticals just raised $20 million in Series A+ funding to support its Phase II oncodermatology trial. The...

BioWorld I Financings for March 31, 2021

Biopharmas raising money in public or private financings, including: 9 Meters, Achilles, Celsion, Design, Edgewise, Humanigen, Ikena, New...

Life Science Leader I How A New Biopharma CEO Approaches Diversity & Inclusion

By Rob Wright Michael McCullar, Ph.D., who joined OnQuality Pharmaceuticals as the company’s CEO in Dec. 2020, shares thoughts on his...

OnQuality Pharmaceuticals Announces Enrollment of First Patient in a Phase II Study to Evaluate...

Seattle, WA—August 14, 2020. OnQuality Pharmaceuticals (USA) LLC, dedicated to the discovery and development of therapies to improve qua...

OnQuality raises $15 million in series A financing

Shanghai, China—Oct. 28th, 2019. OnQuality Pharmaceuticals Ltd., a start-up pharmaceutical company focusing on mitigating on-target toxic...

OnQuality announces FDA clearance of IND for OQL011

Shanghai, China—May 24th, 2019. OnQuality Pharmaceuticals Ltd., today announced the U.S. Food and Drug Administration (FDA) clearance of...